NANoREG D5 07 SOP 09
NANoREG D5.07 SOP 09 TaqMan real-time Reverse Transcription PCR
Acesse:
https://www.rivm.nl/documenten/nanoreg-d507-sop-09-taqman-real-time-reverse-transcription-pcr
NANoREG D5 07 SOP 08
NANoREG D5.07 SOP 08 Cytotoxicity by MTS – reference to NanoValid protocol
Acesse:
NANoREG D5 07 SOP 07
NANoREG D5.07 SOP 07 HEL17T010 Colony forming efficiency assay
Acesse:
https://www.rivm.nl/documenten/nanoreg-d507-sop-07-hel17t010-colony-forming-efficiency-assay
NANoREG D5 07 SOP 06
NANoREG D5.07 SOP 06 HEL16T008 AlamarBlue Assay
Acesse:
https://www.rivm.nl/documenten/nanoreg-d507-sop-06-hel16t008-alamarblue-assay
NANoREG D5 07 SOP 05
NANoREG D5.07 SOP 05 Viability protocol by using a Cell Counter
Acesse:
https://www.rivm.nl/documenten/nanoreg-d507-sop-05-viability-protocol-by-using-a-cell-counter
NANoREG D5 07 SOP 04
NANoREG D5.07 SOP 04 Label-free nanotoxicity assessment by impedance-based flow cytometry
Acesse:
NANoREG D5 07 SOP 03
NANoREG D5.07 SOP 03 SOP for High Throughput Cell Impedance Measurement
Acesse:
NANoREG D5 07 SOP 02
NANoREG D5.07 SOP 02 Real-time label-free impedance-based nanotoxicity assessment
Acesse:
NANoREG D5 07
NANoREG D5.07 SOP 01 SOP for Dispersion
Acesse:
https://www.rivm.nl/documenten/nanoreg-d507-sop-01-sop-for-dispersion
NANoREG D5 06
NANoREG D5 06 DR Identification and optimization of the most suitable in vitro methodology
Acesse:
SOPs available in deliverable:
- SOP 01 LAL Assay for Nanoparticles
- SOP 02 LDH assay
- SOP 03 Reaction Oxygen Species Detection
- SOP 04 Human Lung Cell transformation assay. Long term chronic experiment
- SOP 05 Apoptosis/Necrosis Analysis
- SOP 06 Production of pro-inflammatory cytokines